BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28244805)

  • 1. No impact of eight NTRK2 genetic polymorphisms on 6-month antidepressant efficacy in depressed patients.
    Deflesselle E; Verstuyft C; Petit AC; Hardy P; David DJ; Falissard B; Fève B; Rigal L; Becquemont L; Corruble E; Colle R
    Pharmacogenomics; 2017 Mar; 18(4):349-357. PubMed ID: 28244805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The TRKB rs2289656 genetic polymorphism is associated with acute suicide attempts in depressed patients: A transversal case control study.
    Deflesselle E; Colle R; Rigal L; David DJ; Vievard A; Martin S; Becquemont L; Verstuyft C; Corruble E
    PLoS One; 2018; 13(10):e0205648. PubMed ID: 30308049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans.
    Dong C; Wong ML; Licinio J
    Mol Psychiatry; 2009 Dec; 14(12):1105-18. PubMed ID: 19844206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotrophin Genes and Antidepressant-Worsening Suicidal Ideation: A Prospective Case-Control Study.
    Voegeli G; Ramoz N; Shekhtman T; Courtet P; Gorwood P; Kelsoe JR
    Int J Neuropsychopharmacol; 2016 Nov; 19(11):. PubMed ID: 27378793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BDNF/TRKB/P75NTR polymorphisms and their consequences on antidepressant efficacy in depressed patients.
    Colle R; Deflesselle E; Martin S; David DJ; Hardy P; Taranu A; Falissard B; Verstuyft C; Corruble E
    Pharmacogenomics; 2015; 16(9):997-1013. PubMed ID: 26122862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain-derived neurotrophic factor Val66Met polymorphism and 6-month antidepressant remission in depressed Caucasian patients.
    Colle R; Gressier F; Verstuyft C; Deflesselle E; Lépine JP; Ferreri F; Hardy P; Guilloux JP; Petit AC; Fève B; Falissard B; Becquemont L; Corruble E
    J Affect Disord; 2015 Apr; 175():233-40. PubMed ID: 25658497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harm avoidance involved in mediating the association between nerve growth factor (NGF) gene polymorphisms and antidepressant efficacy in patients with major depressive disorder.
    Yeh YW; Kuo SC; Chen CY; Liang CS; Ho PS; Yen CH; Chen TY; Shyu JF; Wan FJ; Lu RB; Huang SY
    J Affect Disord; 2015 Sep; 183():187-94. PubMed ID: 26021968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
    Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible associations of NTRK2 polymorphisms with antidepressant treatment outcome: findings from an extended tag SNP approach.
    Hennings JM; Kohli MA; Czamara D; Giese M; Eckert A; Wolf C; Heck A; Domschke K; Arolt V; Baune BT; Horstmann S; Brückl T; Klengel T; Menke A; Müller-Myhsok B; Ising M; Uhr M; Lucae S
    PLoS One; 2013; 8(6):e64947. PubMed ID: 23750220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No influence of PTGS2 polymorphisms on response and remission to antidepressants in major depression.
    Serretti A; Chiesa A; Calati R; Massat I; Linotte S; Kasper S; Lecrubier Y; Fink M; Antonijevic I; Forray C; Snyder L; Bollen J; Zohar J; De Ronchi D; Souery D; Mendlewicz J
    Psychiatry Res; 2011 Jun; 188(1):166-9. PubMed ID: 21168919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HTR2A gene variation is involved in antidepressant treatment response.
    Lucae S; Ising M; Horstmann S; Baune BT; Arolt V; Müller-Myhsok B; Holsboer F; Domschke K
    Eur Neuropsychopharmacol; 2010 Jan; 20(1):65-8. PubMed ID: 19758789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain-derived neurotrophic factor ( BDNF) gene: no major impact on antidepressant treatment response.
    Domschke K; Lawford B; Laje G; Berger K; Young R; Morris P; Deckert J; Arolt V; McMahon FJ; Baune BT
    Int J Neuropsychopharmacol; 2010 Feb; 13(1):93-101. PubMed ID: 19236730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinase gene haplotypes and gene-gene interactions in the Ras-Raf-MAPK signaling pathway: association with antidepressant remission.
    Wang CJ; Zhang ZJ; Xu Z; Shi YY; Pu MJ; Zheng Z; Wang XZ; Zhang YM; Li LJ
    Int Clin Psychopharmacol; 2013 Sep; 28(5):245-54. PubMed ID: 23727904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between NTRK2 Polymorphisms, Hippocampal Volumes and Treatment Resistance in Major Depressive Disorder.
    Paolini M; Fortaner-Uyà L; Lorenzi C; Spadini S; Maccario M; Zanardi R; Colombo C; Poletti S; Benedetti F
    Genes (Basel); 2023 Nov; 14(11):. PubMed ID: 38002980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotrophic tyrosine kinase polymorphism impacts white matter connections in patients with major depressive disorder.
    Murphy ML; Carballedo A; Fagan AJ; Morris D; Fahey C; Meaney J; Frodl T
    Biol Psychiatry; 2012 Oct; 72(8):663-70. PubMed ID: 22609366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the TLR4 gene with depressive symptoms and antidepressant efficacy in major depressive disorder.
    Wang J; Yang C; Liu Z; Li X; Liu M; Wang Y; Zhang K; Sun N
    Neurosci Lett; 2020 Sep; 736():135292. PubMed ID: 32763359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Race-Dependent Association of Single-Nucleotide Polymorphisms in TrkB Receptor in People Living with HIV and Depression.
    Avdoshina V; Yumoto F; Mocchetti I; Letendre SL; Tractenberg RE
    Neurotox Res; 2021 Dec; 39(6):1721-1731. PubMed ID: 34613587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of β-arrestin2 polymorphisms with response to antidepressant treatment in depressed patients.
    Petit AC; El Asmar K; David DJ; Gardier AM; Becquemont L; Fève B; Verstuyft C; Corruble E
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():74-79. PubMed ID: 29031912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The FKBP5 polymorphism rs1360780 influences the effect of an algorithm-based antidepressant treatment and is associated with remission in patients with major depression.
    Stamm TJ; Rampp C; Wiethoff K; Stingl J; Mössner R; O Malley G; Ricken R; Seemüller F; Keck M; Fisher R; Gaebel W; Maier W; Möller HJ; Bauer M; Adli M
    J Psychopharmacol; 2016 Jan; 30(1):40-7. PubMed ID: 26645208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder.
    Tsai SJ; Hong CJ; Liou YJ; Chen TJ; Chen ML; Hou SJ; Yen FC; Yu YW
    Psychiatry Res; 2009 Sep; 169(2):113-7. PubMed ID: 19700204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.